CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma

Detalles Bibliográficos
Autores principales: Guo, Yelei, Tong, Chuan, Su, Liping, Zhang, Wenying, Jia, Hejin, Liu, Yang, Yang, Qingming, Wu, Zhiqiang, Wang, Yao, Han, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043938/
https://www.ncbi.nlm.nih.gov/pubmed/35008103
http://dx.doi.org/10.1182/bloodadvances.2021006232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043938/
https://www.ncbi.nlm.nih.gov/pubmed/35008103
http://dx.doi.org/10.1182/bloodadvances.2021006232

Ejemplares similares